BCYC Q2 2022 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+145.3% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$27M-623.6% margin

Net Income

-$27M-612.8% margin

EPS (Diluted)

$-0.90

QoQ Revenue Growth

+13.4%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$32M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$445M

Total Liabilities

$134M

Stockholders' Equity

$311M

Cash & Equivalents

$373M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+145.3%
Gross Profit	$4M	$2M	+145.3%
Operating Income	-$27M	-$17M	-58.0%
Net Income	-$27M	-$18M	-49.8%